Riskpilot← Back to searchSign inGet full accessHJERTESPESIALISTEN AS
ASActiveOrg 916103549Sjøgata 39, 9008 TromsøMedical specialists activities · NACE 8622Est. 20152 employees
Revenue 2024
NOK 5M
+6% vs 2023
EBITDA margin
10.4%
+364% vs 2023
Equity ratio
30.3%
Financial strength
Net profit 2024
NOK 333K
+1870% vs 2023
| Revenue | NOK 5M | +6% |
| EBITDA | NOK 522K | +364% |
| Net profit | NOK 333K | +1870% |
| Total assets | NOK 907K | +8% |
| Equity | NOK 274K | +85% |
| Employees | 2 | — |
Legal name
HJERTESPESIALISTEN AS
Org number
916103549
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. oktober 2015
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Hjerteutredning og medisinsk behandling, konsulentvirksomhet og hva som naturlig står i forbindelse med dette.
Address
Sjøgata 39, 9008 Tromsø
Phone
+4777729777
Email
postmottak@pasientreiser.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 258 | 4 348 | 4 378 | 4 731 | 5 014 |
| Staff expenses | −2 092 | −2 199 | −2 342 | −2 683 | −2 665 |
| EBITDA | 420 | 281 | 107 | 112 | 522 |
| Depreciation & amort. | −124 | −124 | −114 | −112 | −60 |
| EBIT | 296 | 157 | −6 | 1 | 462 |
| Net financials | −65 | −41 | −11 | −4 | 1 |
| Profit before tax | 231 | 116 | −17 | −3 | 464 |
| Tax | 51 | 26 | 16 | −20 | 130 |
| Net profit | 180 | 90 | −33 | 17 | 333 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 300 | 913 | 789 | 843 | 907 |
| Equity | 217 | 196 | 158 | 148 | 274 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 083 | 717 | 631 | 695 | 632 |
| Total debt | 2 083 | 717 | 631 | 695 | 632 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20202024
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
121.5%
This company
18.4%
Market median
+560% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
5.53×
This company
1.12×
Market median
+394% vs market
20202024
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TS | Board of Directors | 2016 |
| Board of Directors | 2026 | |
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sángon As
HJERTESPESIALISTEN AS Board members of HJERTESPESIALISTEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tor Sara | Board of Directors | 0 companies |
| Ina Rye-Holmboe | Board of Directors | 0 companies |
| Johan Eivind Sandvik | Chairman | 0 companies |